Disadvantages of Structured Treatment Interruption Persist in Patients With Multidrug-Resistant HIV-1-Reference-Cited by-同舟云学术

Disadvantages of Structured Treatment Interruption Persist in Patients With Multidrug-Resistant HIV-1

Published:2006-10 Issue:2 Volume:43 Page:169-178
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes

Author:

Lawrence Jody,Hullsiek Katherine Huppler,Thackeray Lisa M,Abrams Donald I,Crane Lawrence R,Mayers Douglas L,Jones Michael C,Saldanha Jennifer M,Schmetter Barry S,Baxter John D

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference25 articles.

1. Simultaneous vs Sequential Initiation of Therapy With Indinavir, Zidovudine, and Lamivudine for HIV-1 Infection

2. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

3. Human Immunodeficiency Virus Rebound after Suppression to <400 Copies/mL during Initial Highly Active Antiretroviral Therapy Regimens, according to Prior Nucleoside Experience and Duration of Suppression

4. Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study

5. Time to Virological Failure of 3 Classes of Antiretrovirals after Initiation of Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study Group

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. References;HIV and the Pathogenesis of AIDS;2014-04-30

2. Antiretroviral Treatment Interruption and Loss to Follow-Up in Two HIV Cohorts in Australia and Asia: Implications for ‘Test and Treat’ Prevention Strategy;AIDS Patient Care and STDs;2013-12

3. Drug-Resistant Virus Has Reduced Ability to Induce Immune Activation;JAIDS Journal of Acquired Immune Deficiency Syndromes;2012-12-01

4. Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future;AIDS Research and Treatment;2012

5. Results of Antiretroviral Treatment Interruption and Intensification in Advanced Multi-Drug Resistant HIV Infection from the OPTIMA Trial;PLoS ONE;2011-03-31